KR830003210A - 미용 및 의학용 조성물의 제조방법 - Google Patents
미용 및 의학용 조성물의 제조방법 Download PDFInfo
- Publication number
- KR830003210A KR830003210A KR1019800003749A KR800003749A KR830003210A KR 830003210 A KR830003210 A KR 830003210A KR 1019800003749 A KR1019800003749 A KR 1019800003749A KR 800003749 A KR800003749 A KR 800003749A KR 830003210 A KR830003210 A KR 830003210A
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- nitric acid
- composition
- solution
- soluble
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims 12
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims 11
- 229910017604 nitric acid Inorganic materials 0.000 claims 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 8
- 229910052751 metal Inorganic materials 0.000 claims 8
- 239000002184 metal Substances 0.000 claims 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 4
- 239000004310 lactic acid Substances 0.000 claims 4
- 235000014655 lactic acid Nutrition 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical class [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims 2
- 125000005907 alkyl ester group Chemical group 0.000 claims 2
- 229910052793 cadmium Inorganic materials 0.000 claims 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical class [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims 2
- 229910052802 copper Inorganic materials 0.000 claims 2
- 239000010949 copper Substances 0.000 claims 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 206010010356 Congenital anomaly Diseases 0.000 claims 1
- 229910002651 NO3 Inorganic materials 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001661 cadmium Chemical class 0.000 claims 1
- WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) Chemical compound [Cd+2] WLZRMCYVCSSEQC-UHFFFAOYSA-N 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 229910001431 copper ion Inorganic materials 0.000 claims 1
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940116333 ethyl lactate Drugs 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 150000001261 hydroxy acids Chemical class 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 210000004400 mucous membrane Anatomy 0.000 claims 1
- 235000006408 oxalic acid Nutrition 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 239000012466 permeate Substances 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
- -1 warm Chemical class 0.000 claims 1
- 229910052725 zinc Chemical class 0.000 claims 1
- 239000011701 zinc Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 미용 및 의학용 분야에 사용되는 조성물의 제조방법으로 이 조성물은 실온 또는 실온 보다 낮은 온도에서 저장할 경우 두가지 주성분의 농도범위에 대해 안정하며 질산 용액에 가용인 아질산금속 0.01-5mg/ml의 양을 6-10mmol/ml 농도의 질산용액 또는 더 진한 질산용액과 반응시킨후 물로 희석하여 6-10mmol/m 질산함량 및 pH 값이 1이하가 되도록 하는 조성물이 제조방법.
- 조성물을 제조하는 청구범위 제 1항의 방법에서 조성물은 질산을 산화시킬수 있는 유기카르복시산을 적어도 하나 그리고 피하에 사용시 독성이 업으며 pH가 1이하인 질산용액에 가용성인 금속염을 적어도 하나 함유하며, 상기의 적어도 하나의 유기카르복시산과 적어도 하나의 금속염을 물에 용해시키고 진한 질산을 첨가하고 선택적으로 물로 희석하여 질산의 농도가 6-10mmole/ml이고 pH가 1 이하가 되도록하며 생성된 용액을 질산용액에 가용성인 아질산금속의 용액고 반응시켜 최종용액이 0.01-5mg/ml의 아질산염(NO2)을 수반하도록 하는 조성물의 제조방법.
- 유기카르복시산으로 히드록시산, 케톤산 및 불포화산으로 이루어진 기로부터 선택된 지방성카르복시산을 사용하여 이루어진 청구범위 제 2항에 의한 방법.
- 지방성카르복시산으로 유산, 수산및 초산을 사용하여 이루어진 청구범위 제 3항에 의한 방법.
- 금속염으로 구리, 온, 카드뮴 및 아연의 가용성염을 사용하여 이루어진 청구범위 제 2항의 의한 방법.
- 구리이온, 카드뮴이온, 진한 질산, 유산 또는 유산의 저급알킬에스테르, 수산 또는 수산디(저급알킬)에스테르, 초산 또는 초산의 저급알킬에스테르 그리고 선택적으로 에탄올을 선정순위에 따라 혼합하고 20-100℃온도에서 액체가 맑고 무색이며 pH가 1이하이고 거의 가스의 커품이 발생하지 않도록 반응을 완결시키고 현성되는 고체에서 부유물을 분리하여 제조하는 청구범위 제2항에 의한 조성물의 제조방법.
- 진한 질산, 수용성 구리(Ⅱ) 염 또는 금속구리를 수용성카드뮴염 또는 금속카드뮴과 각각함께 또는 없는데서 용해하여 반응시키고, 이 용액에 유산 또는 유산에틸 그리고 선택적으로 에탄올용액을 첨가하여 반응시키고, 이 용액에 수산 또는 수산디에틸 그후에 초산 또는 초산에틸을 첨가하여 액체가 맑고 무색이며 pH가 1이하이고 가스의 거품이 거의 발생하지 않도록 반응을 완결한 후 생성된 고체를 제거할 부유물을 분리하며 이때 제조동안의 온도는 냉각 또는 가열로 실온이나 약간 증가된 온도가 되도록 유지시켜 제조하는 청구범위 제 6항에 의한 방법.
- 조성물을 사용하기전에 6-10mmole/ml의 농도이고 pH 가 1이하인 질산수용액에 가용인 아질산금속을 이것은 사용자에게 적합한 기공이 있는 막대에 침투시키거나 또는 스며들게 하는 청구범위 제 1항에 의한 조성물의 제조방법.
- 질산용액에 가용인 아질산금속 0.01-5mg으로 스며들게한 기공이 있으며 사용자에게 적합한 막대로 이루어진 청구범위 제 8항에 의한 제조방법을 수행하는 방법.
- 양성, 선천적악성, 그리고 악성인 유형의 피부 및 점액질막의 피하장해, 특히 외부로부터 치료될 수 없는 종양의 치료를 위한 청구범위 제 1항-제 8항의 어느하나에 의한 조성물의 사용방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH871379A CH629100A5 (de) | 1979-09-27 | 1979-09-27 | Hautpraeparat. |
CH8713 | 1979-09-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR830003210A true KR830003210A (ko) | 1983-06-18 |
KR850001724B1 KR850001724B1 (ko) | 1985-12-07 |
Family
ID=4343859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019800003749A KR850001724B1 (ko) | 1979-09-27 | 1980-09-26 | 화장품 및 약제에 유용한 조성물의 제조방법 |
Country Status (21)
Country | Link |
---|---|
US (1) | US4595591A (ko) |
EP (1) | EP0026532B1 (ko) |
JP (1) | JPS5659706A (ko) |
KR (1) | KR850001724B1 (ko) |
AR (1) | AR224654A1 (ko) |
AT (1) | ATE20183T1 (ko) |
AU (1) | AU538878B2 (ko) |
CA (1) | CA1155058A (ko) |
CH (1) | CH629100A5 (ko) |
DE (1) | DE3071629D1 (ko) |
DK (1) | DK161012C (ko) |
EG (1) | EG15021A (ko) |
ES (1) | ES495330A0 (ko) |
FI (1) | FI73129C (ko) |
GR (1) | GR70008B (ko) |
IL (1) | IL61136A (ko) |
IN (1) | IN154851B (ko) |
PH (1) | PH18810A (ko) |
PL (1) | PL133116B1 (ko) |
SU (1) | SU1382394A3 (ko) |
ZA (1) | ZA805990B (ko) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0151201B1 (de) * | 1982-10-08 | 1986-11-12 | Zvonko Pestelic | Keratolytisches Mittel, geeignet zum Entfernen von Warzen |
CH673225A5 (ko) * | 1986-04-22 | 1990-02-28 | Sanosil Ag | |
US4681687A (en) * | 1986-10-20 | 1987-07-21 | Nalco Chemical Company | Use of alkali metal nitrites to inhibit H2 S formation in flue gas desulfurization system sludges |
US4758426A (en) * | 1987-06-11 | 1988-07-19 | Ramsdell Bruce V | Therapeutic toilet solution and method of dispersion |
US5053024A (en) * | 1989-10-23 | 1991-10-01 | Israel Dvoretzky | Application system and method for treating warts |
GB9308103D0 (en) * | 1993-04-20 | 1993-06-02 | Unilever Plc | Cosmetic composition |
MY128187A (en) * | 1993-06-23 | 2007-01-31 | Icn Switzerland Ag | Preparation for skin and mucous membrane |
US5456904A (en) * | 1993-06-28 | 1995-10-10 | The Procter & Gamble Company | Photoprotection compositions comprising certain chelating agents |
US5407958A (en) * | 1993-07-30 | 1995-04-18 | Beauticontrol Cosmetics, Inc. | Therapeutic skin composition |
US6418556B1 (en) | 1993-09-09 | 2002-07-09 | United Video Properties, Inc. | Electronic television program guide schedule system and method |
FR2715845B1 (fr) * | 1994-02-04 | 1996-03-29 | Oreal | Composition cosmétique et/ou dermatologique contenant du vinaigre. |
US6709681B2 (en) | 1995-02-17 | 2004-03-23 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
EP0717984B1 (en) * | 1994-12-20 | 2004-11-03 | Unilever Plc | Lactate dehydrogenase inhibitors in cosmetic compositions |
SE9700617D0 (sv) * | 1997-02-21 | 1997-02-21 | Kjell Alving | New composition |
GB9905425D0 (en) * | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
US20060200174A1 (en) * | 2001-05-08 | 2006-09-07 | Stough Dowling B | Wart removal method and device |
US6585742B2 (en) | 2001-05-08 | 2003-07-01 | Dowling B. Stough | Wart removal method and device |
US20050054991A1 (en) | 2001-08-29 | 2005-03-10 | Tobyn Michael John | Topical administration device |
US7128903B2 (en) | 2001-10-03 | 2006-10-31 | Innovative Pharmaceutical Concepts (Ipc) Inc. | Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same |
US20030175362A1 (en) * | 2002-01-07 | 2003-09-18 | Kross Robert D. | Disinfecting nitrous acid compositions and process for using the same |
US20060057133A1 (en) * | 2002-03-22 | 2006-03-16 | Ramon Suarez Mendoza | Topical pathogenic-tissue-destroying liquid |
US7780992B2 (en) * | 2002-12-08 | 2010-08-24 | Tareq Abduljalil Albahri | Antiviral medicament |
UA82254C2 (uk) * | 2003-12-03 | 2008-03-25 | Валодя Падиурашвили | Склад та спосіб одержання композиції, фармацевтична композиція та її застосування |
US7258875B2 (en) * | 2003-12-04 | 2007-08-21 | Chiou Consulting, Inc. | Compositions and methods for topical treatment of skin infection |
US7311928B2 (en) * | 2003-12-09 | 2007-12-25 | Briant Burke | Topical compositions containing tea tree oil for treatment of viral lesions |
AU2006204585B2 (en) * | 2005-01-06 | 2011-04-14 | Bennett, David Mr | Composition and method for treatment of residues in pumping, bore, and reticulation equipment |
US7776809B2 (en) * | 2005-01-06 | 2010-08-17 | David Bennett | Composition and method for treatment of residues in pumping, bore and reticulation equipment |
ATE525077T1 (de) | 2008-01-25 | 2011-10-15 | Auriga Internat | Pharmazeutische zusammensetzung enthaltend salpetersäure und einen zinksalz und entsprechende medizinische vorrichtung für die behandlung von hautläsionen |
RU2440816C1 (ru) * | 2010-12-09 | 2012-01-27 | Общество С Ограниченной Ответственностью "Оксигон" | Лекарственное средство, способ его получения и способ применения |
US9446068B2 (en) | 2011-04-22 | 2016-09-20 | Obschestvos S Ogranitchennoi Otvetstvennostju “Oxygon” | Method of production of the stable selenium-comprising pharmaceutical composition with a high selenium level |
RU2482856C2 (ru) | 2011-08-05 | 2013-05-27 | Общество С Ограниченной Ответственностью "Оксигон" | Комплексное соединение 2-хлорпропионата цинка и 2-хлорпропионовой кислоты, фармацевтическая композиция для лечения заболеваний кожи, способ ее получения и способ лечения поражений кожи, ногтей и видимых слизистых |
US20230052709A1 (en) * | 2021-07-29 | 2023-02-16 | Alexander Sepper | Topical antiviral liquid for treatment of warts |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3879537A (en) * | 1973-09-04 | 1975-04-22 | Scott Eugene J Van | Treatment of ichthyosiform dermatoses |
US3988470A (en) * | 1974-02-25 | 1976-10-26 | Scott Eugene J Van | Treatment of palmar and plant disturbed keratosis |
-
1979
- 1979-09-27 CH CH871379A patent/CH629100A5/de not_active IP Right Cessation
-
1980
- 1980-09-22 DE DE8080200887T patent/DE3071629D1/de not_active Expired
- 1980-09-22 EG EG580/80A patent/EG15021A/xx active
- 1980-09-22 AT AT80200887T patent/ATE20183T1/de not_active IP Right Cessation
- 1980-09-22 EP EP80200887A patent/EP0026532B1/de not_active Expired
- 1980-09-24 IL IL61136A patent/IL61136A/xx not_active IP Right Cessation
- 1980-09-25 ES ES495330A patent/ES495330A0/es active Granted
- 1980-09-26 PL PL1980226939A patent/PL133116B1/pl unknown
- 1980-09-26 GR GR62969A patent/GR70008B/el unknown
- 1980-09-26 AR AR282676A patent/AR224654A1/es active
- 1980-09-26 ZA ZA00805990A patent/ZA805990B/xx unknown
- 1980-09-26 CA CA000361137A patent/CA1155058A/en not_active Expired
- 1980-09-26 IN IN698/DEL/80A patent/IN154851B/en unknown
- 1980-09-26 PH PH24641A patent/PH18810A/en unknown
- 1980-09-26 SU SU802990878A patent/SU1382394A3/ru active
- 1980-09-26 FI FI803037A patent/FI73129C/fi not_active IP Right Cessation
- 1980-09-26 KR KR1019800003749A patent/KR850001724B1/ko active
- 1980-09-26 AU AU62758/80A patent/AU538878B2/en not_active Ceased
- 1980-09-26 DK DK407480A patent/DK161012C/da not_active IP Right Cessation
- 1980-09-27 JP JP13509480A patent/JPS5659706A/ja active Granted
-
1983
- 1983-02-07 US US06/464,371 patent/US4595591A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0026532A2 (de) | 1981-04-08 |
JPS5659706A (en) | 1981-05-23 |
FI803037A (fi) | 1981-03-28 |
FI73129C (fi) | 1987-09-10 |
AU6275880A (en) | 1981-04-09 |
EP0026532B1 (de) | 1986-06-04 |
PH18810A (en) | 1985-09-27 |
CH629100A5 (de) | 1982-04-15 |
PL226939A1 (ko) | 1981-08-21 |
EG15021A (en) | 1985-06-30 |
ES8107020A1 (es) | 1981-10-01 |
DE3071629D1 (en) | 1986-07-10 |
PL133116B1 (en) | 1985-05-31 |
ATE20183T1 (de) | 1986-06-15 |
FI73129B (fi) | 1987-05-29 |
EP0026532A3 (en) | 1981-08-19 |
AU538878B2 (en) | 1984-08-30 |
US4595591A (en) | 1986-06-17 |
CA1155058A (en) | 1983-10-11 |
DK161012C (da) | 1991-10-28 |
AR224654A1 (es) | 1981-12-30 |
GR70008B (ko) | 1982-07-23 |
ES495330A0 (es) | 1981-10-01 |
SU1382394A3 (ru) | 1988-03-15 |
IN154851B (ko) | 1984-12-15 |
DK407480A (da) | 1981-03-28 |
ZA805990B (en) | 1981-09-30 |
KR850001724B1 (ko) | 1985-12-07 |
DK161012B (da) | 1991-05-21 |
IL61136A (en) | 1984-02-29 |
JPH0129773B2 (ko) | 1989-06-14 |
IL61136A0 (en) | 1980-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR830003210A (ko) | 미용 및 의학용 조성물의 제조방법 | |
US4154912A (en) | In situ self cross-linking of polyvinyl alcohol battery separators | |
ATE121094T1 (de) | Verfahren zur herstellung von kolloidalen dispersionen von cerdioxid in alkoholischem medium. | |
ES445653A1 (es) | Procedimiento de extraccion de fenoles y oligosacaridos de tejidos vegetales. | |
KR920009749A (ko) | 네오펜틸 글리콜의 제조방법 | |
DE1244151B (de) | Verfahren zur Herstellung von gesaettigten alpha-Di- oder Trimethylolfettsaeuren | |
US2351500A (en) | Process for gluconic acid production | |
US2135111A (en) | Vanadyl lactate and process of making it | |
IL24513A (en) | Iron-containing therapeutic preparations | |
GB1436732A (en) | Preparing metal-carboxylic acid compounds | |
US2317671A (en) | Chemical compound | |
Dewan | Coenzyme-linked reactions involving l (+) glutamic dehydrogenase | |
Baudisch et al. | NEW METHODS OF SPLITTING PYRIMIDINES. IV. A STUDY OF THE MECHANISM OF THE DECOMPOSITION OF THYMINE1 | |
DE411530C (de) | Verfahren zur Darstellung von Oxykodeinon | |
US2356581A (en) | Process of preparing pentone acids and their salts | |
US2162721A (en) | Production of d-ribose from calcium d-altronate | |
GB1285840A (en) | Microbiological oxidation process | |
SU763094A1 (ru) | Состав дл пропитки изделий из древесины | |
FR2027873A1 (en) | Electrodeposition of ruthenium | |
ATE55765T1 (de) | Verfahren zur herstellung von alkylestern der methyltartronsaeure. | |
SU785293A1 (ru) | Способ получени дифенил-2,2 ,6,6тетраальдегида | |
KR830004298A (ko) | 2-치환-6-알콕시카르보닐-8-에틸-5-옥소-5,8-디히드로-피리도-[2,3-d]-피리미딘류 및 그의 유리산의 제조방법 | |
KR840005106A (ko) | 화학적 방법 | |
GB1464794A (en) | Method of preparing globules containing an actinide metal | |
GB1213612A (en) | Process for producing aliphatic and cycloaliphatic alcohols |